Difficulty: Medium
Average Score: 88%
Practice
A 55 year old woman has melaena for 6 weeks and is referred by her GP to gastroenterology. Which is the most appropriate management of her diabetes prior to endoscopy?
Correct answer
D
Rationale
In a psychiatric emergency exam scenario involving a 55-year-old woman with melaena, the most appropriate management of her diabetes prior to endoscopy would be to omit gliclazide on the morning of the procedure (Option D).
The rationale for this choice is that gliclazide is a sulfonylurea, which can potentially cause hypoglycemia. During the endoscopy procedure, the patient may be fasting, which increases the risk of hypoglycemia if gliclazide is taken. Omitting gliclazide on the morning of the procedure helps to minimize this risk.
Regarding the other options:
- Option A: Changing gliclazide to metformin is not the best choice in this scenario as metformin does not directly address the risk of hypoglycemia associated with gliclazide.
- Option B: Changing gliclazide to subcutaneous insulin may be too drastic a change without proper monitoring and adjustment of insulin dosage.
- Option C: Omitting gliclazide for 24 hours prior to the procedure may lead to fluctuations in blood sugar levels and is not as precise as omitting it on the morning of the procedure.
In an educational context, understanding the pharmacological properties of different diabetes medications and their effects on blood sugar levels in relation to fasting periods during medical procedures is crucial for healthcare providers managing patients with diabetes in various clinical scenarios. It is essential to tailor diabetes management strategies to individual patient needs to ensure optimal outcomes and prevent complications like hypoglycemia during procedures.
The rationale for this choice is that gliclazide is a sulfonylurea, which can potentially cause hypoglycemia. During the endoscopy procedure, the patient may be fasting, which increases the risk of hypoglycemia if gliclazide is taken. Omitting gliclazide on the morning of the procedure helps to minimize this risk.
Regarding the other options:
- Option A: Changing gliclazide to metformin is not the best choice in this scenario as metformin does not directly address the risk of hypoglycemia associated with gliclazide.
- Option B: Changing gliclazide to subcutaneous insulin may be too drastic a change without proper monitoring and adjustment of insulin dosage.
- Option C: Omitting gliclazide for 24 hours prior to the procedure may lead to fluctuations in blood sugar levels and is not as precise as omitting it on the morning of the procedure.
In an educational context, understanding the pharmacological properties of different diabetes medications and their effects on blood sugar levels in relation to fasting periods during medical procedures is crucial for healthcare providers managing patients with diabetes in various clinical scenarios. It is essential to tailor diabetes management strategies to individual patient needs to ensure optimal outcomes and prevent complications like hypoglycemia during procedures.